On June 1, 2004, Hong Kong’s Department of Health launched the Center for Health Protection (CHP) under the recommendation from the SARS Expert Committee Report. The CHP will help strengthen Hong Kong’s ability to prevent and control communicable diseases. In order to... Read More
When applying for a Certificate for Clinical Trial/Medicinal Test in Hong Kong, a summary of the pre-clinical studies (or alternate similar information) is now required as part of the application packet. The registration and payment may be submitted Monday through Friday, between... Read More
In July 2003, Hong Kong’s Department of Health (DH) and the Electrical and Mechanical Services Department (EMSD) together released a consultation document entitled “Regulation of Medical Devices in Hong Kong.” Currently, Hong Kong does not have any specific legislation that regulates the... Read More
As Asian countries begin to adopt more western lifestyles and foods, “western” diseases are becoming more prevalent killers in Asia. Economic transition, urbanization, and technological development have brought about lifestyle changes that have increased the chances for heart disease in Asia. Developing... Read More
Compared to the U.S. and many European countries, the biotechnology industry in Asia is embryonic. However, in recent years, several Asian countries have designated the expansion of biotechnology as crucial to their economic development. Some governments in Asia have thus begun taking... Read More
Sales potential for Western medicines in Hong Kong is substantial — approximately $1.6 billion is spent each year. Hong Kong’s pharmaceutical market grew 5.4 percent in 2000, the lowest increase in recent years. And with Hong Kong’s economy floundering, prospects for this... Read More
The US Trade Development Agency (TDA) estimates that developing countries in Asia will spend over $6 billion on healthcare technology over the next five years. There are at least 25 large-scale healthcare technology projects either underway or on the drawing board in... Read More
Despite sluggish economies in some countries, Asia still represents future growth opportunities in healthcare products. Over the next 20 years, Asian healthcare markets are expected to grow at a rate two and a half times that of the West. A rising standard... Read More
Despite Hong Kong’s reversion to China in 1997, under the terms of its return, Hong Kong is exempt from the rules and regulations outlined above for Chinese medical devices. Hong Kong does require general registration of imported medical devices, but there are... Read More
This article contains analyses of healthcare trends and policies, and the role of foreign medical companies in China, Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Thailand and Vietnam. As Asia continues to be the fastest growing region in the world, economic... Read More